Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Omalizumab”

210 trials

Showing 20 of 210 results

Testing effectiveness (Phase 2)Looking for participantsNCT07059091
What this trial is testing

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)Allergies
Johns Hopkins University 334
Testing effectiveness (Phase 2)Study completedNCT01599637
What this trial is testing

Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment

Who this might be right for
Chronic Idiopathic Urticaria
Novartis Pharmaceuticals 40
Not applicableStudy completedNCT05157087
What this trial is testing

XOLAIR (Omalizumab) Outcomes in Pediatric Allergic Asthma Patients in the United States

Who this might be right for
Asthma
Novartis Pharmaceuticals 16,246
Post-approval studies (Phase 4)Study completedNCT00454051
What this trial is testing

Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 31
Large-scale testing (Phase 3)Study completedNCT00180011
What this trial is testing

Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
DiMango, Emily, M.D. 18
Testing effectiveness (Phase 2)Study completedNCT01781637
What this trial is testing

Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial

Who this might be right for
Peanut AllergyFood Allergy
Boston Children's Hospital 36
Post-approval studies (Phase 4)Study completedNCT00495612
What this trial is testing

Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced Asthma

Who this might be right for
Asthma
Genentech, Inc. 69
Post-approval studies (Phase 4)Study completedNCT02023151
What this trial is testing

Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk Expression in Basophils

Who this might be right for
Allergic Asthma
Johns Hopkins University 17
Testing effectiveness (Phase 2)Study completedNCT02169115
What this trial is testing

Urticaria Facticia Treatment With Omalizumab (UFO)

Who this might be right for
Symptomatic Dermographism
Charite University, Berlin, Germany 61
Post-approval studies (Phase 4)Study completedNCT00567476
What this trial is testing

Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma

Who this might be right for
Asthma
Novartis 116
Post-approval studies (Phase 4)Ended earlyNCT03964051
What this trial is testing

Protection From Food Induced Anaphylaxis by Reducing the Serum Level of Specific IgE (Protana).

Who this might be right for
Food Allergy
Carsten Bindslev-Jensen 7
Not applicableUnknownNCT00350376
What this trial is testing

Impact of Asthma Treatments on Daily Activities

Who this might be right for
AsthmaAllergies
Ovation Research Group 1,500
Large-scale testing (Phase 3)Study completedNCT04426890
What this trial is testing

To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Celltrion 634
Testing effectiveness (Phase 2)Study completedNCT00130234
What this trial is testing

Effect of Anti-IgE in Chronic Urticaria

Who this might be right for
Urticaria
Johns Hopkins University 20
Post-approval studies (Phase 4)Study completedNCT04998604
What this trial is testing

EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients

Who this might be right for
Chronic Rhinosinusitis With Nasal PolypsAsthma
Sanofi 360
Post-approval studies (Phase 4)Study completedNCT02300701
What this trial is testing

Role of Anti-IgE in Severe Childhood Eczema

Who this might be right for
Atopic EczemaAtopic DermatitisChild
Guy's and St Thomas' NHS Foundation Trust 62
Large-scale testing (Phase 3)UnknownNCT02124226
What this trial is testing

Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma

Who this might be right for
Low Dose Methotrexate in Severe Chronic Asthma
Universita degli Studi di Catania 102
Testing effectiveness (Phase 2)Study completedNCT00481676
What this trial is testing

Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria

Who this might be right for
Chronic Urticaria
Novartis 49
Not applicableWithdrawnNCT01002976
What this trial is testing

Correlation Between IgE Parameters and the Response to Omalizumab in Subjects With Severe Asthma

Who this might be right for
Severe Allergic Asthma
Carmel Medical Center
Post-approval studies (Phase 4)Study completedNCT00329381
What this trial is testing

Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy

Who this might be right for
Asthma
University of Mississippi Medical Center 14
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation